
### [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518)
**Label:** isolated punctate palmoplantar keratoderma

**Subclasses:** [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), 

**Corr. equiv. classes:** [Orphanet:79501](http://www.orpha.net/ORDO/Orphanet_79501), [OMIM:614936](http://purl.obolibrary.org/obo/OMIM_614936), [Orphanet:307995](http://www.orpha.net/ORDO/Orphanet_307995), [OMIM:148600](http://purl.obolibrary.org/obo/OMIM_148600), 

**Class expressions from DL-Learner:**

- [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 62.50%
- [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) and [HP:0100273](http://purl.obolibrary.org/obo/HP_0100273) (Neoplasm of the colon) 62.50%
- [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 62.50%
- [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 62.50%
- [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0009726](http://purl.obolibrary.org/obo/HP_0009726) (Renal neoplasm) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0009725](http://purl.obolibrary.org/obo/HP_0009725) (Bladder neoplasm) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0007379](http://purl.obolibrary.org/obo/HP_0007379) (Neoplasm of the genitourinary tract) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0100273](http://purl.obolibrary.org/obo/HP_0100273) (Neoplasm of the colon) 62.50%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 62.50%
- [HP:0005584](http://purl.obolibrary.org/obo/HP_0005584) (Renal cell carcinoma) and [HP:0012189](http://purl.obolibrary.org/obo/HP_0012189) (Hodgkin lymphoma) 62.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) 62.50%


